Herbas VPB

Print
EN | LT
LT - Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
EN - Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07H 19/20 (2006.01)
A61K 31/7072 (2006.01)
A61P 31/00 (2006.01)
European patent
(11) Number of the document 2826784
(13) Kind of document T
(96) European patent application number 14179358.8
Date of filing the European patent application 2008-03-26
(97) Date of publication of the European application 2015-01-21
(45) Date of publication and mention of the grant of the patent 2019-06-26
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
909315 P 2007-03-30 US
982309 P 2007-10-24 US
53015 2008-03-21 US
Inventors
(72)
Du, Jinfa, US
Wang, Peiyuan, US
Nagarathnam, Dhanapalan, US
Sofia, Michael Joseph, US
Grantee
(73) Gilead Pharmasset LLC, c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404, US
Title
(54) Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
  Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
Last update date 2021-04-30